Lingnan Modern Clinics In Surgery ›› 2021, Vol. 21 ›› Issue (04): 377-382.DOI: 10.3969/j.issn.1009-976X.2021.04.001
• Comment • Next Articles
LIN Zhi-wen, LIU Hong-zhi, ZENG Yong-yi
Contact:
ZENG Yong-yi, lamp197311@126.com
林志文, 刘红枝, 曾永毅*
通讯作者:
*曾永毅,Email:lamp197311@126.com
作者简介:
曾永毅,医学博士、主任医师、教授、博士生导师, 福建医科大学孟超肝胆医院副院长(主持工作)。中华医学会外科学分会青年委员、中华医学会外科学分会胆道学组委员、国际外科、胃肠及肿瘤科医师协会(IASGO)会员、福建省肝病学分会常务委员兼秘书、福建省肝病学分会肝癌学组副组长。《World Journal of Gastroenterology》编委、合作主持国家自然科学基金2项,个人主持省部级课题9项,第一作者和通讯作者在中华医学会系列杂志发表论著30余篇,SCI收录25篇,最高影响因子14.588,授权国家发明专利7项。获2020年福建医学科技奖二等奖(第一完成人),2018年福建省科学技术进步奖一等奖(第四完成人),2016年福建省第十二届自然科学优秀学术论文一等奖(第一完成人)。
CLC Number:
LIN Zhi-wen, LIU Hong-zhi, ZENG Yong-yi. The controversies and hotspots of lymph node dissection for intrahepatic cholangiocarcinoma[J]. Lingnan Modern Clinics In Surgery, 2021, 21(04): 377-382.
林志文, 刘红枝, 曾永毅. 肝内胆管癌淋巴结清扫的热点与争议[J]. 岭南现代临床外科, 2021, 21(04): 377-382.
Add to citation manager EndNote|Ris|BibTeX
URL: http://www.lingnanwaike.com/EN/10.3969/j.issn.1009-976X.2021.04.001
[1] Wang L, Lin ZG, Ke Q, et al.Adjuvant transarterial chemoembolization following radical resection for intrahepatic cholangiocarcinoma: A multi-center retrospective study[J]. J Cancer, 2020, 11(14): 4115-4122. [2] 曾永毅, 林自国, 刘红枝, 等. 微血管侵犯对肝内胆管癌根治性切除病人预后影响研究: 基于多中心的倾向评分匹配分析[J]. 中国实用外科杂志, 2020, 40(6): 695-702. [3] Liao P, Cao L, Chen H, et al.Analysis of metastasis and survival between extrahepatic and intrahepatic cholangiocarcinoma: A large population-based study[J]. Medicine (Baltimore), 2021, 100(16): e25635. [4] Morine Y, Shimada M.The value of systematic lymph node dissection for intrahepatic cholangiocarcinoma from the viewpoint of liver lymphatics[J]. J Gastroenterol, 2015, 50(9): 913-927. [5] Pupulim LF, Vilgrain V, Ronot M, et al.Hepatic lymphatics: anatomy and related diseases[J]. Abdom Imaging, 2015, 40(6): 1997-2011. [6] 陆巍, 汤朝晖, 全志伟. 肝内胆管癌淋巴结清扫相关问题的探讨[J]. 中华外科杂志, 2019, 57(4): 247-252. [7] Lee AJ, Chun YS.Intrahepatic cholangiocarcinoma: the AJCC/UICC 8th edition updates[J]. Chin Clin Oncol. 2018,7(5):52. [8] 王垒,林自国, 杨田, 等. 淋巴结清扫在肝内胆管癌根治术中临床价值的多中心回顾性研究[J]. 中华消化外科杂志, 2020, 19(1): 72-80. [9] Yin L, Zhao S, Zhu H, et al.Primary tumor resection improves survival in patients with multifocal intrahepatic cholangiocarcinoma based on a population study[J]. Sci Rep, 2021, 11(1): 12166. [10] Zhang XF, Xue F, Dong DH, et al. Number and Station of Lymph Node Metastasis After Curative-intent Resection of Intrahepatic Cholangiocarcinoma Impact Prognosis [J]. Ann Surg, 2020, Jan 14.[Online ahead of print] [11] 陈晨,吴予涵,李起,等. 不同淋巴结分期指标评估肝内胆管癌患者预后的价值探讨[J]. 中华外科杂志,2020,58(4):295-302. [12] Ma K, Dong B, Wang L, et al.Nomograms for predicting overall survival and cancer-specific survival in patients with surgically resected intrahepatic cholangiocarcinoma[J]. Cancer Manag Res, 2019, 11: 6907-6929. [13] 白惠惠. 胃癌淋巴结转移的分期与影像学诊断研究进展[J]. 中国临床新医学, 2019, 12(12): 1345-1349. [14] Jiang L, Tan H, Panje CM, et al.Role of 18F-FDG PET/CT Imaging in Intrahepatic Cholangiocarcinoma[J]. Clin Nucl Med, 2016, 41(1): 1-7. [15] Huang X, Yang J, Li J, et al.Comparison of magnetic resonance imaging and 18-fludeoxyglucose positron emission tomography/computed tomography in the diagnostic accuracy of staging in patients with cholangiocarcinoma: A meta-analysis[J]. Medicine (Baltimore), 2020, 99(35): e20932. [16] Navarro JG, Lee JH, Kang I, et al.Prognostic significance of and risk prediction model for lymph node metastasis in resectable intrahepatic cholangiocarcinoma: do all require lymph node dissection?[J]. HPB (Oxford), 2020, 22(10): 1411-1419. [17] Lisotti A, Ricci C, Serrani M, et al.Contrast-enhanced endoscopic ultrasound for the differential diagnosis between benign and malignant lymph nodes: a meta-analysis[J]. Endosc Int Open, 2019, 7(4): E504-E513. [18] Malikowski T, Levy MJ, Gleeson FC, et al.Endoscopic Ultrasound/Fine Needle Aspiration Is Effective for Lymph Node Staging in Patients With Cholangiocarcinoma[J]. Hepatology, 2020, 72(3): 940-948. [19] 於雷,代智,王征,等. 淋巴结转移对肝内胆管细胞癌患者预后的影响及临床相关因素研究[J]. 中国癌症杂志, 2020, 30(9): 694-700. [20] Meng ZW, Lin XQ, Zhu JH, et al.A nomogram to predict lymph node metastasis before resection in intrahepatic cholangiocarcinoma[J]. J Surg Res, 2018, 226: 56-63. [21] Ji GW, Zhu FP, Zhang YD, et al.A radiomics approach to predict lymph node metastasis and clinical outcome of intrahepatic cholangiocarcinoma[J]. Eur Radiol, 2019,29(7):3725-3735. [22] Xu L, Yang P, Liang W, et al.A radiomics approach based on support vector machine using MR images for preoperative lymph node status evaluation in intrahepatic cholangiocarcinoma[J]. Theranostics, 2019, 9(18):5374-5385. [23] Kizy S, Altman AM, Marmor S, et al.Surgical resection of lymph node positive intrahepatic cholangiocarcinoma may not improve survival[J]. HPB (Oxford), 2019, 21(2): 235-241. [24] Bridgewater J, Galle PR, Khan SA, et al.Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma[J]. J Hepatol, 2014, 60(6): 1268-1289. [25] Weber SM, Ribero D, O′Reilly EM, et al. Intrahepatic cholangiocarcinoma: expert consensus statement[J]. HPB (Oxford), 2015, 17(8): 669-680. [26] 中国抗癌协会肝癌专业委员会. 中国肝癌多学科综合治疗专家共识[J]. 临床肝胆病杂志, 2021, 37(2): 278-285. [27] Nakagawa T, Kamiyama T, Kurauchi N, et al.Number of lymph node metastases is a significant prognostic factor in intrahepatic cholangiocarcinoma[J]. World J Surg, 2005, 29(6): 728-733. [28] Yoh T, Hatano E, Nishio T, et al.Significant Improvement in Outcomes of Patients with Intrahepatic Cholangiocarcinoma after Surgery[J]. World J Surg, 2016, 40(9): 2229-2236. [29] Li DY, Zhang HB, Yang N, et al.Routine lymph node dissection may be not suitable for all intrahepatic cholangiocarcinoma patients: results of a monocentric series[J]. World J Gastroenterol, 2013, 19(47): 9084-9091. [30] Kang CM, Suh KS, Yi NJ, et al.Should Lymph Nodes Be Retrieved in Patients with Intrahepatic Cholangiocarcinoma? A Collaborative Korea-Japan Study[J]. Cancers (Basel), 2021, 13(3): 445. [31] Zhou R, Lu D, Li W, et al.Is lymph node dissection necessary for resectable intrahepatic cholangiocarcinoma? A systematic review and meta-analysis[J]. HPB (Oxford), 2019, 21(7): 784-792. [32] Shimada M, Yamashita Y, Aishima S, et al.Value of lymph node dissection during resection of intrahepatic cholangiocarcinoma[J]. Br J Surg, 2001, 88(11): 1463-1466. [33] Nozaki Y, Yamamoto M, Ikai I, et al.Reconsideration of the lymph node metastasis pattern (N factor) from intrahepatic cholangiocarcinoma using the International Union Against Cancer TNM staging system for primary liver carcinoma[J]. Cancer, 1998, 83(9): 1923-1929. [34] Yoh T, Cauchy F, Le Roy B, et al.Prognostic value of lymphadenectomy for long-term outcomes in node-negative intrahepatic cholangiocarcinoma: A multicenter study[J]. Surgery, 2019, 166(6): 975-982. [35] Ke Q, Wang L, Lin Z, et al.Prognostic Value of Lymph Node Dissection for Intrahepatic Cholangiocarcinoma Patients With Clinically Negative Lymph Node Metastasis: A Multi-Center Study From China[J]. Front Oncol, 2021, 11: 585808. [36] Mazzaferro V, Gorgen A, Roayaie S, et al.Liver resection and transplantation for intrahepatic cholangiocarcinoma[J]. J Hepatol, 2020, 72(2): 364-377. [37] Bagante F, Gani F, Spolverato G, et al. Intrahepatic Cholangiocarcinoma: Prognosis of Patients Who Did Not Undergo Lymphadenectomy [J]. J Am Coll Surg, 2015, 221(6): 1031-1040. e1-4. [38] Hu LS, Zhang XF, Weiss M, et al.Recurrence Patterns and Timing Courses Following Curative-Intent Resection for Intrahepatic Cholangiocarcinoma[J]. Ann Surg Oncol, 2019, 26(8): 2549-2557. [39] Hu J, Chen F Y, Zhou K Q, et al.Intrahepatic cholangiocarcinoma patients without indications of lymph node metastasis not benefit from lymph node dissection[J]. Oncotarget, 2017, 8(69): 113817-113827. [40] 黄徐建, 杨发才, 李梦, 等. 肝切除联合淋巴结清扫对临床淋巴结阴性肝内胆管癌患者预后的价值[J]. 中华肝脏外科手术学电子杂志, 2020, 9(6): 533-537. [41] Benson AB, D′Angelica MI, Abbott DE, et al. Guidelines Insights: Hepatobiliary Cancers, Version 2. 2019[J]. J Natl Compr Canc Netw, 2019, 17(4): 302-310. [42] 梁后杰,秦叔逵,沈锋,等. CSCO胆道系统肿瘤诊断治疗专家共识(2019年版)[J]. 临床肿瘤学杂志, 2019, 24(9): 828-838. [43] 王冲,程石. 肝内胆管癌——国内外专家共识及指南解读[J]. 外科理论与实践, 2021, 26(2): 124-129. [44] Kim DH, Choi DW, Choi SH, et al.Is there a role for systematic hepatic pedicle lymphadenectomy in intrahepatic cholangiocarcinoma? A review of 17 years of experience in a tertiary institution[J]. Surgery, 2015, 157(4): 666-675. [45] Choi SB, Kim KS, Choi JY, et al.The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival[J]. Ann Surg Oncol, 2009, 16(11): 3048-3056. [46] Kim SH, Han DH, Choi GH, et al.Recommended Minimal Number of Harvested Lymph Nodes for Intrahepatic Cholangiocarcinoma[J]. J Gastrointest Surg, 2021, 25(5): 1164-1171. [47] Brauer DG, Fields RC, Tan BR Jr, et al.Optimal extent of surgical and pathologic lymph node evaluation for resected intrahepatic cholangiocarcinoma[J]. HPB (Oxford), 2018, 20(5): 470-476. [48] Martin SP, Drake J, Wach MM, et al.Laparoscopic Approach to Intrahepatic Cholangiocarcinoma is Associated with an Exacerbation of Inadequate Nodal Staging[J]. Ann Surg Oncol, 2019, 26(6): 1851-1857. [49] Machairas N, Kostakis ID, Schizas D, et al.Meta-analysis of laparoscopic versus open liver resection for intrahepatic cholangiocarcinoma[J]. Updates Surg, 2021, 73(1): 59-68. [50] 罗柳平, 李建伟, 曹利, 等. 腹腔镜肝切除术治疗肝内胆管癌的临床疗效[J]. 中华消化外科杂志, 2019, 18(2): 169-175. [51] 张军, 梁博, 付晓伟, 等. 肝内胆管癌根治术不同淋巴结清扫方式对淋巴结检出数目及预后的影响[J]. 中华消化外科杂志, 2020, 19(2): 191-195. [52] Yamashita Y, Taketomi A, Morita K, et al.The impact of surgical treatment and poor prognostic factors for patients with intrahepatic cholangiocarcinoma: retrospective analysis of 60 patients[J]. Anticancer Res, 2008, 28(4C): 2353-2359. [53] Watanabe Y, Matsuyama Y, Izumi N, et al.Effect of surgical margin width after R0 resection for intrahepatic cholangiocarcinoma: A nationwide survey of the Liver Cancer Study Group of Japan[J]. Surgery, 2020, 167(5): 793-802. [54] Farges O, Fuks D, Boleslawski E, et al. Influence of surgical margins on outcome in patients with intrahepatic cholangiocarcinoma: a multicenter study by the AFC-IHCC-2009 study group [J]. Ann Surg, 2011, 254(5): 824-829, discussion 830. [55] Altman AM, Kizy S, Marmor S, et al.Adjuvant chemotherapy for intrahepatic cholangiocarcinoma: approaching clinical practice consensus?[J]. Hepatobiliary Surg Nutr, 2020, 9(5): 577-586. [56] Ke Q, Lin N, Deng M, et al.The effect of adjuvant therapy for patients with intrahepatic cholangiocarcinoma after surgical resection: A systematic review and meta-analysis[J]. PLoS One, 2020, 15(2): e0229292. [57] Wang L, Lin ZG, Ke Q, et al.Adjuvant transarterial chemoembolization following radical resection for intrahepatic cholangiocarcinoma: A multi-center retrospective study[J]. J Cancer, 2020, 11(14): 4115-4122. [58] Wang L, Deng M, Ke Q, et al.Postoperative adjuvant therapy following radical resection for intrahepatic cholangiocarcinoma: A multicenter retrospective study[J]. Cancer Med, 2020, 9(8): 2674-2685. |
[1] | Liu Wei. Five-year follow-up analysis of clinical efficacy of radiotherapy alone and radiochemotherapy in malignant glioma [J]. Lingnan Modern Clinics In Surgery, 2022, 22(1): 89-93. |
[2] | KONG Ling-qi, QU Yan-lin, ZHU Fan-he. Current status of diagnosis and treatment of testicular tumors in children [J]. Lingnan Modern Clinics In Surgery, 2021, 21(06): 684-687. |
[3] | WU Zhuo-peng, YANG Jie. Prevention and treatment of chylothorax in thoracic surgery [J]. Lingnan Modern Clinics In Surgery, 2021, 21(06): 688-692. |
[4] | LU Xu, LI Hua, YI Shu-hong, ZHAO Hui, ZHU Shu-guang, LI Hai-bo, YANG Yang, WANG Guo-ying. Transarterial chemoembolization combined with Lenvatinib bridging in the treatment of 2 patients with hepatocellular carcinoma exceeding Milan standard liver transplantation [J]. Lingnan Modern Clinics In Surgery, 2021, 21(05): 507-511. |
[5] | HUANG Guo-hui, LIU Yan-ping, WANG Sheng-yan, ZHANG Long. Clinicopathological analysis of 56 cases of splenic metastatic tumor [J]. Lingnan Modern Clinics In Surgery, 2021, 21(05): 526-530. |
[6] | SHEN Tao, LU Zhu-ming, DUAN Chu-xiao, ZHANG Dong-xi, YE min, LIN Zhi-chao. Lymph node metastasis of simultaneous multiple primary lung cancer [J]. Lingnan Modern Clinics In Surgery, 2021, 21(05): 561-565. |
[7] | YANG Wen-qian, LIN Wan-yi, GONG Chang. Characteristics on diagnosis and treatment of breast cancer patients with liver metastasis [J]. Lingnan Modern Clinics In Surgery, 2021, 21(03): 272-277. |
[8] | GAO Zhen-hua, WANG Jun-hong, WAN Yu-ping, SHAO E-ling, WANG Xing-sheng, QIAN Hong-liang, LV Peng-xiang, RAN Ya-zhen. Clinical experience in the treatment of autoimmune pancreatitis [J]. Lingnan Modern Clinics In Surgery, 2021, 21(03): 329-332. |
[9] | LI Hao-quan, YE Zhen-wei, CHEN Shi-xing, JIANG Jing-zhu, WANG Zai-guo. Diagnosis and treatment of undifferentiated sarcoma of the liver in adults: a case report and the literature review [J]. Lingnan Modern Clinics In Surgery, 2021, 21(03): 349-351. |
[10] | LI Yue, LV Guo-qing. Optimized utilization of clinical and laboratory parameters in the diagnosis of acute appendicitis [J]. Lingnan Modern Clinics In Surgery, 2021, 21(02): 209-212. |
[11] | LOU Wen-hui. Whole disease journey management in the diagnosis and treatment of pancreatic cancer [J]. Lingnan Modern Clinics In Surgery, 2021, 21(01): 1-5. |
[12] | LIN Jie, LIU Qing-bo, HE Wei, MA Jing, CHEN Yun-hao, WANG Wei-dong. Expression and significance of 8-Nitroguanine in intrahepatic cholangiocarcinoma with liver fluke infection [J]. Lingnan Modern Clinics In Surgery, 2021, 21(01): 59-62. |
[13] | KONG Heng, CHEN Ji-xin. Primary angiosarcoma of the breast: a case report and literature review [J]. Lingnan Modern Clinics In Surgery, 2021, 21(01): 104-107. |
[14] | ZHAN Shang-xin, LIU Xing-bin, GU Xu-ying, JIANG Shui-hua, CHEN Ding-guang, ZHANG Lin. Analysis of the related factors and prevention and treatment of the complications of laparoscopic inguinal hernia repair [J]. Lingnan Modern Clinics in Surgery, 2020, 20(06): 715-718. |
[15] | GAO Min-nan, ZHNAG Lu, YANG Yan-qi, JIANG Hui-qi, ZENG Kuan, WANG Meng. Diagnosis and treatment of acute fibrinous and organizing pneumonia due to allergic reaction and literature review [J]. Lingnan Modern Clinics in Surgery, 2020, 20(06): 723-728. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||